Insider Transactions in Q2 2022 at Ironwood Pharmaceuticals Inc (IRWD)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2022
|
Thomas A Mccourt Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
19,959
-2.5%
|
$219,549
$11.58 P/Share
|
|
Jun 15
2022
|
Alexander J Denner |
BUY
Grant, award, or other acquisition
|
Direct |
1,222
+1.35%
|
-
|
|
Jun 14
2022
|
Marla L Kessler |
SELL
Open market or private sale
|
Direct |
7,610
-8.29%
|
$83,710
$11.65 P/Share
|
|
Jun 07
2022
|
Mark G Currie |
SELL
Open market or private sale
|
Direct |
190,383
-24.34%
|
$2,284,596
$12.01 P/Share
|
|
Jun 07
2022
|
Mark G Currie |
BUY
Exercise of conversion of derivative security
|
Direct |
190,383
+19.58%
|
$2,094,213
$11.65 P/Share
|
|
Jun 01
2022
|
Andrew Dreyfus |
BUY
Grant, award, or other acquisition
|
Direct |
21,571
+12.45%
|
-
|
|
Jun 01
2022
|
Marla L Kessler |
BUY
Grant, award, or other acquisition
|
Direct |
21,571
+19.03%
|
-
|
|
Jun 01
2022
|
Catherine Moukheibir |
BUY
Grant, award, or other acquisition
|
Direct |
21,571
+17.84%
|
-
|
|
Jun 01
2022
|
Jon R Duane |
BUY
Grant, award, or other acquisition
|
Direct |
21,571
+19.03%
|
-
|
|
Jun 01
2022
|
Julie Mc Hugh |
BUY
Grant, award, or other acquisition
|
Direct |
21,571
+13.36%
|
-
|
|
Jun 01
2022
|
Jay Shepard |
BUY
Grant, award, or other acquisition
|
Direct |
21,571
+21.26%
|
-
|
|
Jun 01
2022
|
Mark G Currie |
BUY
Grant, award, or other acquisition
|
Direct |
21,571
+3.52%
|
-
|
|
Jun 01
2022
|
Alexander J Denner |
BUY
Grant, award, or other acquisition
|
Direct |
21,571
+19.66%
|
-
|
|
May 23
2022
|
Jason Rickard SVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
13,537
-1.62%
|
$148,907
$11.5 P/Share
|
|
May 23
2022
|
Michael Shetzline CMO,SVP,Head-Res&Drug |
SELL
Open market or private sale
|
Direct |
10,583
-1.93%
|
$116,413
$11.5 P/Share
|
|
May 23
2022
|
Ronald Silver Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
120
-0.11%
|
$1,320
$11.5 P/Share
|
|
May 23
2022
|
Thomas A Mccourt Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,308
-1.47%
|
$399,388
$11.5 P/Share
|